Back to results
CompletedPhase 2

SGLT2 Inhibition in Hemodialysis

NCT05179668

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Dialyseinstitut Dr. Waller

Feldbach, Austria

+8 additional locations

View on ClinicalTrials.gov
SGLT2 Inhibition in Hemodialysis — TrialFind